Literature DB >> 8617070

The effect of physical therapy on respiratory complications following cardiac valve surgery.

D Johnson1, C Kelm, D Thomson, B Burbridge, I Mayers.   

Abstract

STUDY
OBJECTIVE: To determine whether higher personnel intensive chest physical therapy can prevent the atelectasis that routinely follows cardiac valve surgery.
DESIGN: Randomized, controlled trial.
SETTING: Tertiary care hospital. PATIENTS: Seventy-eight patients undergoing elective cardiac valve surgery between October 1991 and April 1993 were enrolled.
INTERVENTIONS: Patients were randomized in an unmasked fashion to receive early mobilization and sustained maximal inflations (lower-intensity treatment) or to receive early mobilization, sustained maximal inflations, and single-handed percussions (higher-intensity treatment.) MEASUREMENTS AND
RESULTS: Clinical efficacy was determined by extent of atelectasis, length of ICU stay, total length of hospital stay, and personnel costs. The extent of postoperative atelectasis was similar in both groups on the fifth postoperative day. Postoperative values of FVC and FEV1 were reduced to a similar extent in both groups. Hospital stays and ICU stays were similar regardless of treatment. Physical therapy costs were highest in the higher-intensity therapy group.
CONCLUSIONS: Postoperative respiratory dysfunction is common but does not usually cause significant morbidity or prolong hospital stay. The routine prescription of high-intensity physical therapy does not improve patient outcomes but does add significantly to patient costs.

Entities:  

Mesh:

Year:  1996        PMID: 8617070     DOI: 10.1378/chest.109.3.638

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Clinician's Commentary.

Authors:  Tania Larsen
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

2.  Phase I of cardiac rehabilitation: A new challenge for evidence based physiotherapy.

Authors:  Rafael Michel de Macedo; José Rocha Faria-Neto; Costantino Ortiz Costantini; Dayane Casali; Andrea Pires Muller; Costantino Roberto Costantini; Katherine Athayde Teixeira de Carvalho; Luiz César Guarita-Souza
Journal:  World J Cardiol       Date:  2011-07-26

Review 3.  Improving the appropriateness and effectiveness of ICU practices.

Authors:  M H Kollef
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

Review 4.  Prophylactic respiratory physiotherapy after cardiac surgery: systematic review.

Authors:  Patrick Pasquina; Martin R Tramèr; Bernhard Walder
Journal:  BMJ       Date:  2003-12-13

Review 5.  Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery.

Authors:  Morihiro Katsura; Akira Kuriyama; Taro Takeshima; Shunichi Fukuhara; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05

6.  Exercise-based cardiac rehabilitation for adults after heart valve surgery.

Authors:  Lizette N Abraham; Kirstine L Sibilitz; Selina K Berg; Lars H Tang; Signe S Risom; Jane Lindschou; Rod S Taylor; Britt Borregaard; Ann-Dorthe Zwisler
Journal:  Cochrane Database Syst Rev       Date:  2021-05-07

7.  The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury.

Authors:  K Davis; J A Johannigman; R S Campbell; A Marraccini; F A Luchette; S B Frame; R D Branson
Journal:  Crit Care       Date:  2000-01-29       Impact factor: 9.097

8.  A propose of pulmonary dysfunction stratification after valve surgery by physiotherapeutic assistance level.

Authors:  Satiko Shimada Franco; Luiz Marcelo Sá Malbouisson; Max Grinberg; Maria Ignêz Zanetti Feltrim
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

9.  Incidence and risk factors of Pulmonary Complications after Cardiopulmonary bypass.

Authors:  Anjum Naveed; Hammad Azam; Humayoun Ghulam Murtaza; Rana Altaf Ahmad; Mirza Ahmad Raza Baig
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.